| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Constipation | 53 | 2024 | 546 | 8.050 |
Why?
|
| Manometry | 39 | 2023 | 445 | 7.240 |
Why?
|
| Gastroesophageal Reflux | 28 | 2023 | 782 | 5.610 |
Why?
|
| Gastrointestinal Diseases | 33 | 2024 | 1170 | 4.590 |
Why?
|
| Gastrointestinal Motility | 26 | 2023 | 225 | 4.560 |
Why?
|
| Irritable Bowel Syndrome | 17 | 2024 | 445 | 4.030 |
Why?
|
| Fecal Incontinence | 18 | 2021 | 239 | 3.600 |
Why?
|
| Esophagus | 23 | 2020 | 1019 | 3.300 |
Why?
|
| Esophageal Achalasia | 8 | 2022 | 90 | 3.060 |
Why?
|
| Abdominal Pain | 26 | 2024 | 1064 | 2.910 |
Why?
|
| Defecation | 14 | 2023 | 188 | 2.910 |
Why?
|
| Esophageal pH Monitoring | 15 | 2022 | 191 | 2.770 |
Why?
|
| Eosinophilic Esophagitis | 11 | 2023 | 168 | 2.740 |
Why?
|
| Anal Canal | 16 | 2022 | 376 | 2.690 |
Why?
|
| Electric Impedance | 20 | 2023 | 729 | 2.670 |
Why?
|
| Child | 172 | 2024 | 77709 | 1.740 |
Why?
|
| Rectum | 12 | 2022 | 904 | 1.660 |
Why?
|
| Gastric Emptying | 9 | 2022 | 233 | 1.570 |
Why?
|
| Bisacodyl | 5 | 2023 | 12 | 1.510 |
Why?
|
| Esophagitis | 12 | 2021 | 152 | 1.480 |
Why?
|
| Fundoplication | 5 | 2022 | 138 | 1.380 |
Why?
|
| Gastroenterology | 10 | 2023 | 538 | 1.330 |
Why?
|
| Dyspepsia | 5 | 2024 | 116 | 1.270 |
Why?
|
| Hirschsprung Disease | 8 | 2017 | 155 | 1.260 |
Why?
|
| Laxatives | 6 | 2021 | 87 | 1.260 |
Why?
|
| Colon | 15 | 2023 | 1772 | 1.180 |
Why?
|
| Capsule Endoscopy | 2 | 2020 | 125 | 1.140 |
Why?
|
| Gastrointestinal Agents | 12 | 2021 | 494 | 1.090 |
Why?
|
| Gastroparesis | 6 | 2022 | 131 | 1.060 |
Why?
|
| Pressure | 6 | 2018 | 1203 | 1.050 |
Why?
|
| Cough | 3 | 2014 | 555 | 1.030 |
Why?
|
| Adolescent | 111 | 2024 | 85779 | 1.000 |
Why?
|
| Esophagitis, Peptic | 4 | 2010 | 78 | 0.990 |
Why?
|
| Eosinophilia | 9 | 2022 | 541 | 0.980 |
Why?
|
| Child, Preschool | 87 | 2023 | 41005 | 0.980 |
Why?
|
| Esophageal Motility Disorders | 3 | 2017 | 44 | 0.970 |
Why?
|
| Gastrointestinal Transit | 5 | 2022 | 96 | 0.930 |
Why?
|
| Bile Acids and Salts | 2 | 2021 | 368 | 0.860 |
Why?
|
| Enema | 5 | 2018 | 141 | 0.860 |
Why?
|
| Deglutition Disorders | 8 | 2015 | 606 | 0.840 |
Why?
|
| Fecal Impaction | 4 | 2018 | 34 | 0.810 |
Why?
|
| Hydrogen-Ion Concentration | 12 | 2016 | 2556 | 0.790 |
Why?
|
| Duodenal Diseases | 2 | 2017 | 102 | 0.750 |
Why?
|
| Colonic Diseases, Functional | 3 | 2023 | 38 | 0.740 |
Why?
|
| Diagnostic Techniques, Digestive System | 3 | 2020 | 47 | 0.730 |
Why?
|
| Cisapride | 6 | 2011 | 22 | 0.730 |
Why?
|
| Jejunum | 2 | 2021 | 480 | 0.720 |
Why?
|
| Domperidone | 1 | 2019 | 23 | 0.720 |
Why?
|
| Neuromuscular Agents | 3 | 2012 | 134 | 0.710 |
Why?
|
| Esophageal Sphincter, Lower | 2 | 2012 | 19 | 0.670 |
Why?
|
| Benzofurans | 2 | 2021 | 140 | 0.670 |
Why?
|
| Humans | 207 | 2024 | 744366 | 0.670 |
Why?
|
| Muscle Contraction | 4 | 2021 | 1235 | 0.640 |
Why?
|
| Respiratory Sounds | 2 | 2013 | 696 | 0.640 |
Why?
|
| Botulinum Toxins, Type A | 3 | 2012 | 213 | 0.640 |
Why?
|
| Reflex | 4 | 2022 | 365 | 0.610 |
Why?
|
| Psychophysiologic Disorders | 1 | 2019 | 228 | 0.610 |
Why?
|
| Muscle Relaxation | 4 | 2012 | 142 | 0.610 |
Why?
|
| Gastroenteritis | 1 | 2019 | 245 | 0.600 |
Why?
|
| Intestinal Pseudo-Obstruction | 3 | 2023 | 48 | 0.600 |
Why?
|
| Male | 129 | 2024 | 350115 | 0.590 |
Why?
|
| Infant | 49 | 2023 | 35134 | 0.580 |
Why?
|
| Female | 130 | 2024 | 380193 | 0.580 |
Why?
|
| Radiography, Abdominal | 3 | 2022 | 537 | 0.580 |
Why?
|
| Gastric Acidity Determination | 4 | 2011 | 62 | 0.580 |
Why?
|
| Feeding and Eating Disorders of Childhood | 1 | 2016 | 37 | 0.570 |
Why?
|
| Urinary Tract Physiological Phenomena | 1 | 2016 | 11 | 0.560 |
Why?
|
| Esophagogastric Junction | 5 | 2022 | 313 | 0.560 |
Why?
|
| Respiratory Tract Diseases | 3 | 2008 | 722 | 0.560 |
Why?
|
| Enteral Nutrition | 8 | 2020 | 767 | 0.560 |
Why?
|
| Myoelectric Complex, Migrating | 3 | 2023 | 13 | 0.530 |
Why?
|
| Immunoglobulin E | 8 | 2020 | 1463 | 0.530 |
Why?
|
| Propofol | 1 | 2022 | 629 | 0.520 |
Why?
|
| Receptors, IgE | 6 | 2020 | 389 | 0.520 |
Why?
|
| Serotonin 5-HT4 Receptor Agonists | 1 | 2014 | 11 | 0.510 |
Why?
|
| Gastric Acid | 3 | 2016 | 104 | 0.510 |
Why?
|
| Proton Pump Inhibitors | 4 | 2022 | 526 | 0.510 |
Why?
|
| Vomiting | 6 | 2023 | 637 | 0.500 |
Why?
|
| Quality of Life | 17 | 2021 | 12802 | 0.500 |
Why?
|
| Stomach | 5 | 2017 | 697 | 0.500 |
Why?
|
| Mucous Membrane | 3 | 2023 | 673 | 0.490 |
Why?
|
| Encopresis | 3 | 2003 | 19 | 0.490 |
Why?
|
| Breast Feeding | 2 | 2022 | 1338 | 0.480 |
Why?
|
| Urodynamics | 1 | 2016 | 347 | 0.480 |
Why?
|
| Botulinum Toxins | 3 | 2022 | 191 | 0.470 |
Why?
|
| Diarrhea | 5 | 2024 | 1348 | 0.460 |
Why?
|
| Cyproheptadine | 1 | 2013 | 21 | 0.460 |
Why?
|
| Serotonin Antagonists | 1 | 2013 | 144 | 0.430 |
Why?
|
| Retrospective Studies | 44 | 2022 | 77460 | 0.430 |
Why?
|
| Diagnosis, Differential | 18 | 2019 | 12961 | 0.430 |
Why?
|
| Peristalsis | 3 | 2012 | 60 | 0.410 |
Why?
|
| Pepsin A | 1 | 2011 | 71 | 0.410 |
Why?
|
| Acalculous Cholecystitis | 2 | 2019 | 7 | 0.410 |
Why?
|
| Hospital Costs | 2 | 2015 | 985 | 0.400 |
Why?
|
| Prospective Studies | 30 | 2024 | 53290 | 0.390 |
Why?
|
| Conscious Sedation | 1 | 2015 | 528 | 0.380 |
Why?
|
| Duodenum | 4 | 2023 | 484 | 0.380 |
Why?
|
| Short Bowel Syndrome | 3 | 2011 | 345 | 0.380 |
Why?
|
| Upper Gastrointestinal Tract | 3 | 2023 | 48 | 0.370 |
Why?
|
| Electrochemical Techniques | 1 | 2011 | 98 | 0.370 |
Why?
|
| Food Hypersensitivity | 4 | 2020 | 622 | 0.370 |
Why?
|
| Oropharynx | 1 | 2011 | 127 | 0.370 |
Why?
|
| Esophageal Diseases | 1 | 2011 | 167 | 0.370 |
Why?
|
| Guideline Adherence | 2 | 2018 | 2265 | 0.370 |
Why?
|
| Parasympatholytics | 1 | 2010 | 91 | 0.370 |
Why?
|
| Deglutition | 1 | 2012 | 198 | 0.370 |
Why?
|
| Langerhans Cells | 1 | 2010 | 173 | 0.360 |
Why?
|
| Mast Cells | 5 | 2020 | 1544 | 0.360 |
Why?
|
| Gyrus Cinguli | 1 | 2016 | 1091 | 0.360 |
Why?
|
| Treatment Outcome | 32 | 2024 | 63107 | 0.360 |
Why?
|
| Rectal Diseases | 2 | 2009 | 143 | 0.360 |
Why?
|
| Urinary Bladder | 1 | 2016 | 1173 | 0.350 |
Why?
|
| Feces | 4 | 2021 | 1401 | 0.340 |
Why?
|
| Quality Improvement | 2 | 2022 | 3749 | 0.340 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2011 | 768 | 0.340 |
Why?
|
| Parents | 12 | 2021 | 3405 | 0.330 |
Why?
|
| Neural Pathways | 2 | 2018 | 2974 | 0.330 |
Why?
|
| Spinal Cord Diseases | 1 | 2011 | 298 | 0.320 |
Why?
|
| Insurance, Health | 1 | 2021 | 2494 | 0.320 |
Why?
|
| RNA, Messenger | 6 | 2018 | 13035 | 0.320 |
Why?
|
| Health Expenditures | 1 | 2021 | 2349 | 0.320 |
Why?
|
| Polyethylene Glycols | 3 | 2011 | 1182 | 0.310 |
Why?
|
| Radionuclide Imaging | 3 | 2020 | 2031 | 0.300 |
Why?
|
| Physicians | 2 | 2019 | 4567 | 0.300 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2021 | 3020 | 0.300 |
Why?
|
| Receptors, Fc | 1 | 2010 | 541 | 0.290 |
Why?
|
| Chronic Disease | 13 | 2023 | 9145 | 0.290 |
Why?
|
| X-Rays | 2 | 2022 | 301 | 0.290 |
Why?
|
| Octreotide | 2 | 2016 | 145 | 0.290 |
Why?
|
| Pediatrics | 5 | 2020 | 3475 | 0.290 |
Why?
|
| Pylorus | 2 | 2020 | 86 | 0.280 |
Why?
|
| Postprandial Period | 3 | 2016 | 292 | 0.280 |
Why?
|
| Urinary Incontinence | 1 | 2011 | 496 | 0.280 |
Why?
|
| Severity of Illness Index | 16 | 2017 | 15535 | 0.280 |
Why?
|
| Health Communication | 2 | 2021 | 214 | 0.280 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 8642 | 0.270 |
Why?
|
| Toilet Training | 2 | 2003 | 18 | 0.270 |
Why?
|
| Naltrexone | 1 | 2008 | 307 | 0.270 |
Why?
|
| Prefrontal Cortex | 1 | 2016 | 2147 | 0.260 |
Why?
|
| Macrophages, Alveolar | 1 | 2008 | 407 | 0.260 |
Why?
|
| Pelvic Floor | 2 | 2020 | 138 | 0.260 |
Why?
|
| Postoperative Complications | 4 | 2011 | 15297 | 0.240 |
Why?
|
| Crohn Disease | 2 | 2016 | 2304 | 0.240 |
Why?
|
| Diet | 2 | 2022 | 7937 | 0.240 |
Why?
|
| Gallbladder Emptying | 1 | 2003 | 15 | 0.240 |
Why?
|
| Corn Oil | 1 | 2003 | 29 | 0.240 |
Why?
|
| Psyllium | 1 | 2023 | 2 | 0.230 |
Why?
|
| Double-Blind Method | 9 | 2024 | 12025 | 0.230 |
Why?
|
| Narcotic Antagonists | 1 | 2008 | 562 | 0.230 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2009 | 576 | 0.230 |
Why?
|
| Case-Control Studies | 12 | 2018 | 21748 | 0.220 |
Why?
|
| Attitude of Health Personnel | 2 | 2021 | 3841 | 0.220 |
Why?
|
| Sensitivity and Specificity | 9 | 2019 | 14723 | 0.210 |
Why?
|
| Intestinal Atresia | 2 | 2011 | 68 | 0.210 |
Why?
|
| Monitoring, Physiologic | 3 | 2006 | 1739 | 0.210 |
Why?
|
| Monosaccharides | 1 | 2022 | 70 | 0.210 |
Why?
|
| Attitude to Health | 3 | 2015 | 2052 | 0.200 |
Why?
|
| Ileostomy | 1 | 2022 | 119 | 0.200 |
Why?
|
| Disaccharides | 1 | 2022 | 171 | 0.200 |
Why?
|
| Peptides | 2 | 2024 | 4410 | 0.200 |
Why?
|
| Gastrointestinal Hemorrhage | 3 | 2003 | 1131 | 0.200 |
Why?
|
| Meningomyelocele | 1 | 2022 | 165 | 0.200 |
Why?
|
| Sacrum | 1 | 2003 | 288 | 0.200 |
Why?
|
| Spinal Cord | 2 | 2011 | 1810 | 0.190 |
Why?
|
| Dermatitis, Atopic | 2 | 2019 | 654 | 0.190 |
Why?
|
| Enteritis | 1 | 2022 | 165 | 0.190 |
Why?
|
| Melanosis | 1 | 2021 | 78 | 0.190 |
Why?
|
| Urinary Bladder Diseases | 1 | 2021 | 166 | 0.190 |
Why?
|
| Brain Mapping | 1 | 2016 | 6670 | 0.190 |
Why?
|
| Food, Formulated | 2 | 1998 | 109 | 0.180 |
Why?
|
| Nausea | 2 | 2022 | 674 | 0.180 |
Why?
|
| Gastritis | 1 | 2022 | 196 | 0.180 |
Why?
|
| Young Adult | 13 | 2022 | 56429 | 0.180 |
Why?
|
| Gene Expression Profiling | 2 | 2015 | 9445 | 0.180 |
Why?
|
| Colonoscopy | 3 | 2018 | 1367 | 0.180 |
Why?
|
| Cost of Illness | 3 | 2021 | 1860 | 0.180 |
Why?
|
| Gastrostomy | 2 | 2003 | 310 | 0.180 |
Why?
|
| Cerebral Cortex | 1 | 2016 | 5709 | 0.180 |
Why?
|
| Colonic Diseases | 1 | 2021 | 202 | 0.180 |
Why?
|
| Allergens | 4 | 2020 | 1320 | 0.180 |
Why?
|
| Omeprazole | 1 | 2020 | 112 | 0.170 |
Why?
|
| Lipid Metabolism | 1 | 2008 | 1889 | 0.170 |
Why?
|
| Neurotoxins | 1 | 2020 | 237 | 0.170 |
Why?
|
| Colitis | 3 | 2008 | 1170 | 0.170 |
Why?
|
| Endoscopy | 3 | 2020 | 1787 | 0.170 |
Why?
|
| Cecostomy | 1 | 2018 | 10 | 0.170 |
Why?
|
| Barium Sulfate | 4 | 2000 | 180 | 0.170 |
Why?
|
| Pyloric Antrum | 1 | 2018 | 69 | 0.170 |
Why?
|
| Dumping Syndrome | 1 | 1998 | 18 | 0.160 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2022 | 868 | 0.160 |
Why?
|
| Awards and Prizes | 1 | 2023 | 375 | 0.160 |
Why?
|
| Follow-Up Studies | 14 | 2018 | 39052 | 0.160 |
Why?
|
| Esophageal Atresia | 1 | 2021 | 201 | 0.160 |
Why?
|
| Referral and Consultation | 3 | 2015 | 3531 | 0.160 |
Why?
|
| Starch | 1 | 1998 | 81 | 0.160 |
Why?
|
| Vasoactive Intestinal Peptide | 2 | 1989 | 179 | 0.160 |
Why?
|
| Reference Values | 5 | 2020 | 4982 | 0.160 |
Why?
|
| Gallbladder Diseases | 1 | 2019 | 125 | 0.160 |
Why?
|
| Consensus | 4 | 2022 | 2960 | 0.150 |
Why?
|
| Cathartics | 3 | 2012 | 125 | 0.150 |
Why?
|
| Milk Hypersensitivity | 1 | 1999 | 76 | 0.150 |
Why?
|
| Muscle, Smooth | 4 | 2009 | 934 | 0.150 |
Why?
|
| Inflammatory Bowel Diseases | 3 | 2017 | 2428 | 0.150 |
Why?
|
| Eosinophils | 4 | 2013 | 955 | 0.150 |
Why?
|
| Thoracoscopy | 1 | 2018 | 178 | 0.150 |
Why?
|
| Radiography | 7 | 2004 | 7023 | 0.150 |
Why?
|
| Infant, Newborn | 11 | 2023 | 25628 | 0.150 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2022 | 652 | 0.150 |
Why?
|
| Physician-Patient Relations | 2 | 2021 | 3229 | 0.150 |
Why?
|
| Laryngoscopy | 1 | 2022 | 710 | 0.140 |
Why?
|
| Anxiety | 6 | 2021 | 4293 | 0.140 |
Why?
|
| Pain Measurement | 3 | 2023 | 3420 | 0.140 |
Why?
|
| Wiskott-Aldrich Syndrome Protein | 1 | 2017 | 160 | 0.140 |
Why?
|
| Cross-Sectional Studies | 6 | 2021 | 25039 | 0.140 |
Why?
|
| Amitriptyline | 3 | 2014 | 110 | 0.140 |
Why?
|
| Tooth Erosion | 1 | 2016 | 9 | 0.140 |
Why?
|
| Cattle | 1 | 2022 | 3922 | 0.140 |
Why?
|
| Adult | 21 | 2024 | 214052 | 0.140 |
Why?
|
| Biopsy | 5 | 2017 | 6755 | 0.140 |
Why?
|
| Child Nutrition Disorders | 1 | 1997 | 149 | 0.130 |
Why?
|
| Fibroblast Growth Factors | 1 | 2021 | 878 | 0.130 |
Why?
|
| Age Factors | 7 | 2015 | 18373 | 0.130 |
Why?
|
| Bronchoscopy | 2 | 2013 | 862 | 0.130 |
Why?
|
| Chickens | 1 | 1997 | 865 | 0.130 |
Why?
|
| Phytotherapy | 1 | 1997 | 298 | 0.130 |
Why?
|
| Hospitalization | 1 | 2015 | 10259 | 0.130 |
Why?
|
| Watchful Waiting | 1 | 2019 | 492 | 0.130 |
Why?
|
| Barrett Esophagus | 1 | 1999 | 494 | 0.130 |
Why?
|
| Ectodermal Dysplasia | 2 | 2008 | 106 | 0.130 |
Why?
|
| Urination Disorders | 1 | 2016 | 241 | 0.120 |
Why?
|
| Interleukin-10 | 1 | 2020 | 1200 | 0.120 |
Why?
|
| Medicine | 1 | 2023 | 946 | 0.120 |
Why?
|
| Brain Diseases | 1 | 2024 | 1563 | 0.120 |
Why?
|
| Boston | 3 | 2017 | 9312 | 0.120 |
Why?
|
| Tooth | 1 | 2016 | 207 | 0.120 |
Why?
|
| Algorithms | 5 | 2019 | 13882 | 0.120 |
Why?
|
| Stomach Diseases | 1 | 2015 | 134 | 0.120 |
Why?
|
| Meat | 1 | 1997 | 592 | 0.120 |
Why?
|
| Chi-Square Distribution | 3 | 2009 | 3508 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 5 | 2018 | 7282 | 0.120 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2021 | 1222 | 0.120 |
Why?
|
| Basophils | 1 | 2016 | 389 | 0.120 |
Why?
|
| Receptors, Scavenger | 1 | 2014 | 121 | 0.120 |
Why?
|
| Time Factors | 8 | 2021 | 40075 | 0.120 |
Why?
|
| Hematoma | 1 | 1998 | 758 | 0.120 |
Why?
|
| Perception | 1 | 2020 | 1198 | 0.110 |
Why?
|
| Posture | 2 | 2011 | 958 | 0.110 |
Why?
|
| Th2 Cells | 1 | 2018 | 1061 | 0.110 |
Why?
|
| Spinal Dysraphism | 1 | 2015 | 161 | 0.110 |
Why?
|
| Analysis of Variance | 4 | 2012 | 6366 | 0.110 |
Why?
|
| Antigens, CD1d | 1 | 2014 | 220 | 0.110 |
Why?
|
| Depression | 1 | 2013 | 7759 | 0.110 |
Why?
|
| Outpatient Clinics, Hospital | 2 | 2015 | 392 | 0.110 |
Why?
|
| Lung | 1 | 2011 | 9857 | 0.110 |
Why?
|
| Hospitals, Pediatric | 3 | 2011 | 1775 | 0.110 |
Why?
|
| Diet Therapy | 1 | 2014 | 154 | 0.110 |
Why?
|
| Education, Medical, Continuing | 1 | 2018 | 840 | 0.110 |
Why?
|
| ROC Curve | 2 | 2010 | 3528 | 0.100 |
Why?
|
| Chemokines, CXC | 1 | 2014 | 422 | 0.100 |
Why?
|
| Intestines | 2 | 2016 | 1924 | 0.100 |
Why?
|
| Circadian Rhythm | 1 | 2004 | 2624 | 0.100 |
Why?
|
| Analgesics, Opioid | 1 | 2008 | 3677 | 0.100 |
Why?
|
| Ostomy | 1 | 2011 | 27 | 0.100 |
Why?
|
| Endoscopy, Digestive System | 1 | 2014 | 345 | 0.100 |
Why?
|
| Glutathione Transferase | 1 | 2013 | 595 | 0.100 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2011 | 120 | 0.100 |
Why?
|
| Surgical Stomas | 1 | 2011 | 43 | 0.100 |
Why?
|
| Injections, Intralesional | 1 | 2012 | 276 | 0.100 |
Why?
|
| Predictive Value of Tests | 6 | 2019 | 15078 | 0.100 |
Why?
|
| Catheterization | 2 | 2018 | 1470 | 0.100 |
Why?
|
| Lymphocytes | 1 | 2019 | 2617 | 0.100 |
Why?
|
| Research Design | 2 | 2022 | 5984 | 0.100 |
Why?
|
| Prevalence | 6 | 2022 | 15221 | 0.100 |
Why?
|
| Postoperative Care | 1 | 2017 | 1487 | 0.090 |
Why?
|
| Esophagoscopy | 3 | 2008 | 390 | 0.090 |
Why?
|
| Natural Killer T-Cells | 1 | 2014 | 316 | 0.090 |
Why?
|
| Radiopharmaceuticals | 1 | 2020 | 2645 | 0.090 |
Why?
|
| Supine Position | 1 | 2011 | 205 | 0.090 |
Why?
|
| Gastroscopy | 1 | 2012 | 207 | 0.090 |
Why?
|
| Electrolytes | 1 | 2011 | 282 | 0.090 |
Why?
|
| Analgesics, Non-Narcotic | 2 | 2014 | 366 | 0.090 |
Why?
|
| Enterocolitis | 1 | 2011 | 102 | 0.090 |
Why?
|
| Health Care Surveys | 1 | 2017 | 2453 | 0.090 |
Why?
|
| Critical Illness | 3 | 2020 | 2670 | 0.090 |
Why?
|
| Prone Position | 1 | 2011 | 194 | 0.090 |
Why?
|
| Injections, Intramuscular | 2 | 2009 | 552 | 0.090 |
Why?
|
| Autoimmune Diseases | 1 | 2022 | 2134 | 0.090 |
Why?
|
| Gallbladder | 2 | 2019 | 302 | 0.090 |
Why?
|
| Gastrointestinal Tract | 1 | 2016 | 814 | 0.090 |
Why?
|
| Emergency Service, Hospital | 2 | 2022 | 7658 | 0.090 |
Why?
|
| Urination | 1 | 2011 | 204 | 0.090 |
Why?
|
| Peptide PHI | 1 | 1989 | 4 | 0.090 |
Why?
|
| Myasthenic Syndromes, Congenital | 1 | 2009 | 18 | 0.090 |
Why?
|
| I-kappa B Kinase | 2 | 2008 | 252 | 0.090 |
Why?
|
| Decision Trees | 1 | 2011 | 506 | 0.090 |
Why?
|
| Self Report | 3 | 2016 | 3553 | 0.090 |
Why?
|
| Receptors, Gastrointestinal Hormone | 1 | 1989 | 38 | 0.090 |
Why?
|
| Reproducibility of Results | 8 | 2023 | 19905 | 0.080 |
Why?
|
| Cholecystectomy | 2 | 2019 | 395 | 0.080 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2009 | 150 | 0.080 |
Why?
|
| Pain | 2 | 2017 | 4988 | 0.080 |
Why?
|
| Neuropeptide Y | 1 | 1990 | 200 | 0.080 |
Why?
|
| Sodium Chloride | 1 | 2011 | 625 | 0.080 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2017 | 1164 | 0.080 |
Why?
|
| Blood Cells | 1 | 2010 | 309 | 0.080 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2018 | 2305 | 0.080 |
Why?
|
| Intestinal Mucosa | 1 | 2019 | 3037 | 0.080 |
Why?
|
| Medication Adherence | 2 | 2017 | 2063 | 0.080 |
Why?
|
| Apnea | 1 | 2009 | 195 | 0.080 |
Why?
|
| Comorbidity | 3 | 2015 | 10388 | 0.080 |
Why?
|
| Brain | 3 | 2024 | 26388 | 0.080 |
Why?
|
| Syndrome | 1 | 2014 | 3252 | 0.080 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2008 | 205 | 0.080 |
Why?
|
| Decision Support Techniques | 1 | 2017 | 1956 | 0.080 |
Why?
|
| Constriction, Pathologic | 1 | 2011 | 1107 | 0.080 |
Why?
|
| Piperidines | 1 | 1996 | 1602 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2011 | 3873 | 0.070 |
Why?
|
| Remission Induction | 1 | 2013 | 2385 | 0.070 |
Why?
|
| Hematologic Diseases | 1 | 2011 | 498 | 0.070 |
Why?
|
| North America | 2 | 2021 | 1249 | 0.070 |
Why?
|
| Activities of Daily Living | 2 | 2014 | 2419 | 0.070 |
Why?
|
| Acetaminophen | 2 | 2024 | 545 | 0.070 |
Why?
|
| Medical Staff, Hospital | 1 | 2011 | 601 | 0.070 |
Why?
|
| Dietary Fiber | 2 | 2023 | 760 | 0.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2021 | 3922 | 0.070 |
Why?
|
| Cerebral Palsy | 1 | 2011 | 459 | 0.070 |
Why?
|
| Cell Count | 1 | 2010 | 1856 | 0.070 |
Why?
|
| Patient Satisfaction | 2 | 2021 | 3395 | 0.070 |
Why?
|
| Inflammation | 3 | 2022 | 10637 | 0.070 |
Why?
|
| Laparoscopy | 1 | 2018 | 2150 | 0.070 |
Why?
|
| Disability Evaluation | 1 | 2014 | 1828 | 0.070 |
Why?
|
| Obesity | 2 | 2009 | 12746 | 0.070 |
Why?
|
| Animals | 13 | 2022 | 168768 | 0.070 |
Why?
|
| Mental Recall | 1 | 2012 | 1206 | 0.070 |
Why?
|
| Complementary Therapies | 1 | 2010 | 486 | 0.070 |
Why?
|
| Clinical Competence | 2 | 2021 | 4687 | 0.070 |
Why?
|
| Diagnostic Imaging | 1 | 2020 | 3508 | 0.070 |
Why?
|
| Medical Records | 1 | 2011 | 1413 | 0.070 |
Why?
|
| Health Surveys | 2 | 2018 | 4036 | 0.070 |
Why?
|
| Length of Stay | 2 | 2018 | 6311 | 0.070 |
Why?
|
| Opossums | 3 | 1990 | 106 | 0.060 |
Why?
|
| Colitis, Ulcerative | 2 | 2016 | 1911 | 0.060 |
Why?
|
| Muscle, Skeletal | 1 | 2020 | 4925 | 0.060 |
Why?
|
| Energy Intake | 2 | 2011 | 2148 | 0.060 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2008 | 547 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2016 | 35425 | 0.060 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2008 | 372 | 0.060 |
Why?
|
| Food | 2 | 2020 | 772 | 0.060 |
Why?
|
| Metabolomics | 1 | 2013 | 1485 | 0.060 |
Why?
|
| Gene Expression | 2 | 2017 | 7798 | 0.060 |
Why?
|
| Observer Variation | 1 | 2010 | 2593 | 0.060 |
Why?
|
| Psychometrics | 3 | 2021 | 3003 | 0.060 |
Why?
|
| Tetrodotoxin | 3 | 1990 | 259 | 0.060 |
Why?
|
| Propionates | 1 | 2004 | 169 | 0.060 |
Why?
|
| Factor Analysis, Statistical | 2 | 2017 | 977 | 0.060 |
Why?
|
| Recovery of Function | 1 | 2013 | 2926 | 0.060 |
Why?
|
| United States | 8 | 2023 | 69872 | 0.060 |
Why?
|
| Baclofen | 1 | 2003 | 129 | 0.050 |
Why?
|
| Mitochondrial Encephalomyopathies | 1 | 2002 | 37 | 0.050 |
Why?
|
| Probability | 1 | 2008 | 2506 | 0.050 |
Why?
|
| Hypohidrosis | 1 | 2002 | 29 | 0.050 |
Why?
|
| Treatment Failure | 1 | 2008 | 2618 | 0.050 |
Why?
|
| Intestine, Small | 2 | 2023 | 1240 | 0.050 |
Why?
|
| Societies, Medical | 3 | 2023 | 3743 | 0.050 |
Why?
|
| Endosonography | 2 | 2003 | 610 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2008 | 10943 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2014 | 12244 | 0.050 |
Why?
|
| Biofeedback, Psychology | 2 | 2000 | 115 | 0.050 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2004 | 255 | 0.050 |
Why?
|
| Hernia, Hiatal | 1 | 2002 | 79 | 0.050 |
Why?
|
| Esophageal Neoplasms | 1 | 2011 | 1585 | 0.050 |
Why?
|
| Time | 1 | 2003 | 542 | 0.050 |
Why?
|
| Anaphylaxis | 2 | 2019 | 746 | 0.050 |
Why?
|
| Cheese | 1 | 2020 | 38 | 0.050 |
Why?
|
| Swine | 2 | 2009 | 5918 | 0.050 |
Why?
|
| Prognosis | 5 | 2018 | 29060 | 0.050 |
Why?
|
| Glycine | 1 | 2004 | 671 | 0.050 |
Why?
|
| Patient Compliance | 1 | 2011 | 2684 | 0.050 |
Why?
|
| Androstadienes | 1 | 2002 | 345 | 0.050 |
Why?
|
| Parenteral Nutrition, Total | 2 | 2016 | 302 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 18034 | 0.040 |
Why?
|
| Surface-Active Agents | 1 | 2000 | 159 | 0.040 |
Why?
|
| Gene Expression Regulation | 3 | 2013 | 12073 | 0.040 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2020 | 153 | 0.040 |
Why?
|
| Neurologic Examination | 1 | 2003 | 931 | 0.040 |
Why?
|
| Eggs | 1 | 2020 | 184 | 0.040 |
Why?
|
| Mitochondrial Diseases | 1 | 2003 | 320 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 1989 | 2865 | 0.040 |
Why?
|
| Cell Degranulation | 1 | 2020 | 287 | 0.040 |
Why?
|
| Haptoglobins | 1 | 2020 | 165 | 0.040 |
Why?
|
| Rotation | 1 | 2001 | 523 | 0.040 |
Why?
|
| Primary Health Care | 1 | 2015 | 4557 | 0.040 |
Why?
|
| Age of Onset | 2 | 2017 | 3270 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 2 | 2019 | 6386 | 0.040 |
Why?
|
| Glutathione | 1 | 2001 | 590 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2021 | 779 | 0.040 |
Why?
|
| Urinary Bladder, Neurogenic | 1 | 1979 | 165 | 0.040 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2000 | 370 | 0.040 |
Why?
|
| Communication Barriers | 1 | 2021 | 398 | 0.040 |
Why?
|
| Biliary Tract | 1 | 2019 | 134 | 0.040 |
Why?
|
| Attitude | 1 | 2003 | 776 | 0.040 |
Why?
|
| Food Additives | 1 | 1997 | 19 | 0.040 |
Why?
|
| Absorption | 1 | 1997 | 248 | 0.040 |
Why?
|
| Rehydration Solutions | 1 | 1997 | 47 | 0.040 |
Why?
|
| Acute Disease | 2 | 1998 | 7147 | 0.040 |
Why?
|
| Risk Factors | 3 | 2015 | 72296 | 0.040 |
Why?
|
| Injections | 1 | 2020 | 840 | 0.040 |
Why?
|
| Pharmacogenetics | 1 | 2021 | 674 | 0.040 |
Why?
|
| Dilatation | 1 | 2018 | 291 | 0.040 |
Why?
|
| Gastrointestinal Contents | 1 | 2017 | 34 | 0.040 |
Why?
|
| Interleukin-13 | 1 | 2019 | 389 | 0.040 |
Why?
|
| Decision Making | 1 | 2011 | 3888 | 0.040 |
Why?
|
| Wiskott-Aldrich Syndrome | 1 | 2017 | 131 | 0.040 |
Why?
|
| Sex Factors | 1 | 2011 | 10400 | 0.040 |
Why?
|
| Family Conflict | 1 | 2017 | 95 | 0.040 |
Why?
|
| Organic Chemicals | 1 | 1997 | 211 | 0.040 |
Why?
|
| Receptors, Interleukin-1 Type I | 1 | 2016 | 30 | 0.030 |
Why?
|
| Cysteine | 1 | 2001 | 873 | 0.030 |
Why?
|
| Suction | 1 | 2017 | 267 | 0.030 |
Why?
|
| Health Literacy | 1 | 2021 | 414 | 0.030 |
Why?
|
| Protein Precursors | 1 | 2020 | 1154 | 0.030 |
Why?
|
| Comprehension | 1 | 2021 | 610 | 0.030 |
Why?
|
| Milk | 1 | 1999 | 450 | 0.030 |
Why?
|
| Logistic Models | 3 | 2014 | 13409 | 0.030 |
Why?
|
| Medical History Taking | 1 | 1999 | 784 | 0.030 |
Why?
|
| Contrast Media | 2 | 1999 | 5300 | 0.030 |
Why?
|
| Physician Assistants | 1 | 2018 | 192 | 0.030 |
Why?
|
| Permeability | 1 | 1997 | 738 | 0.030 |
Why?
|
| Interleukin-4 | 1 | 2019 | 1147 | 0.030 |
Why?
|
| Cohort Studies | 3 | 2018 | 40559 | 0.030 |
Why?
|
| Causality | 1 | 2002 | 1275 | 0.030 |
Why?
|
| Incidence | 3 | 2018 | 20952 | 0.030 |
Why?
|
| Placebos | 1 | 2000 | 1676 | 0.030 |
Why?
|
| Respiration, Artificial | 2 | 2017 | 2569 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 1998 | 1151 | 0.030 |
Why?
|
| Communicable Disease Control | 1 | 2021 | 856 | 0.030 |
Why?
|
| Nurse Practitioners | 1 | 2018 | 269 | 0.030 |
Why?
|
| Nutritive Value | 1 | 1997 | 339 | 0.030 |
Why?
|
| Phenotype | 3 | 2017 | 16367 | 0.030 |
Why?
|
| Interleukins | 1 | 2019 | 791 | 0.030 |
Why?
|
| Vitamin A | 1 | 1997 | 615 | 0.030 |
Why?
|
| Caregivers | 2 | 2017 | 2095 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2011 | 9274 | 0.030 |
Why?
|
| Ovalbumin | 1 | 2016 | 719 | 0.030 |
Why?
|
| Nutrition Assessment | 1 | 1997 | 723 | 0.030 |
Why?
|
| Dairy Products | 1 | 1997 | 498 | 0.030 |
Why?
|
| Sickness Impact Profile | 1 | 2015 | 302 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2017 | 1590 | 0.030 |
Why?
|
| Electric Stimulation | 2 | 1990 | 1767 | 0.030 |
Why?
|
| Physical Examination | 1 | 1999 | 1237 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2010 | 9955 | 0.030 |
Why?
|
| Autoantibodies | 1 | 2022 | 2036 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2020 | 8319 | 0.030 |
Why?
|
| Ambulatory Care | 1 | 2004 | 2708 | 0.030 |
Why?
|
| Immunization | 1 | 2017 | 1256 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2021 | 2682 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2017 | 1655 | 0.030 |
Why?
|
| Health Status Indicators | 1 | 2018 | 970 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2002 | 1790 | 0.030 |
Why?
|
| Disease Outbreaks | 1 | 2021 | 1771 | 0.030 |
Why?
|
| Cytokines | 2 | 2020 | 7323 | 0.030 |
Why?
|
| Interleukin-23 | 1 | 2013 | 194 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2018 | 1147 | 0.030 |
Why?
|
| Proctocolectomy, Restorative | 1 | 1994 | 189 | 0.030 |
Why?
|
| Physicians, Primary Care | 1 | 2018 | 592 | 0.020 |
Why?
|
| Fasting | 1 | 1997 | 1592 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 1998 | 1301 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2014 | 940 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2017 | 2634 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2009 | 12721 | 0.020 |
Why?
|
| Citrulline | 1 | 2011 | 105 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 1888 | 0.020 |
Why?
|
| Patient-Centered Care | 1 | 2021 | 1438 | 0.020 |
Why?
|
| Folic Acid | 1 | 1997 | 1300 | 0.020 |
Why?
|
| Chemotaxis | 1 | 2014 | 607 | 0.020 |
Why?
|
| Antibody Affinity | 1 | 2011 | 254 | 0.020 |
Why?
|
| Eating | 1 | 1997 | 1536 | 0.020 |
Why?
|
| Child Health Services | 1 | 2016 | 667 | 0.020 |
Why?
|
| Abdomen | 1 | 2017 | 1118 | 0.020 |
Why?
|
| Recurrence | 2 | 2003 | 8340 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2008 | 5445 | 0.020 |
Why?
|
| Guanethidine | 1 | 1990 | 15 | 0.020 |
Why?
|
| Pyrilamine | 1 | 1990 | 12 | 0.020 |
Why?
|
| Methysergide | 1 | 1990 | 28 | 0.020 |
Why?
|
| Gastroschisis | 1 | 2011 | 97 | 0.020 |
Why?
|
| Lumbosacral Plexus | 1 | 1990 | 53 | 0.020 |
Why?
|
| Up-Regulation | 2 | 2014 | 4222 | 0.020 |
Why?
|
| Pyridostigmine Bromide | 1 | 2009 | 31 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2015 | 867 | 0.020 |
Why?
|
| Atropine | 1 | 1990 | 244 | 0.020 |
Why?
|
| Receptors, Vasoactive Intestinal Peptide | 1 | 1989 | 9 | 0.020 |
Why?
|
| Indomethacin | 1 | 1990 | 332 | 0.020 |
Why?
|
| Tachyphylaxis | 1 | 1989 | 51 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2013 | 976 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2019 | 10483 | 0.020 |
Why?
|
| Heart Transplantation | 1 | 2002 | 3112 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2017 | 11366 | 0.020 |
Why?
|
| Blepharoptosis | 1 | 2009 | 143 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2011 | 1683 | 0.020 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2003 | 3524 | 0.020 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2009 | 238 | 0.020 |
Why?
|
| Reference Standards | 1 | 2011 | 1025 | 0.020 |
Why?
|
| Mice | 3 | 2020 | 81201 | 0.020 |
Why?
|
| Midazolam | 1 | 2009 | 270 | 0.020 |
Why?
|
| Curriculum | 1 | 2021 | 3605 | 0.020 |
Why?
|
| Health Personnel | 1 | 2021 | 3219 | 0.020 |
Why?
|
| Naloxone | 1 | 1990 | 367 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 1999 | 3611 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2000 | 9849 | 0.020 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2011 | 341 | 0.020 |
Why?
|
| Sepsis | 1 | 2001 | 2593 | 0.020 |
Why?
|
| K562 Cells | 1 | 2008 | 635 | 0.020 |
Why?
|
| Risk | 1 | 1999 | 9688 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2008 | 17446 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2016 | 6459 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2015 | 1373 | 0.020 |
Why?
|
| Genotype | 1 | 2021 | 12952 | 0.020 |
Why?
|
| Growth Hormone-Releasing Hormone | 1 | 1988 | 213 | 0.020 |
Why?
|
| Parenteral Nutrition | 1 | 2011 | 650 | 0.020 |
Why?
|
| Cell Movement | 1 | 2018 | 5218 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 1997 | 2897 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2020 | 23404 | 0.020 |
Why?
|
| Linear Models | 1 | 2016 | 5953 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2011 | 1730 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2014 | 1584 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2009 | 1202 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2013 | 2204 | 0.020 |
Why?
|
| Skin | 1 | 2019 | 4372 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2000 | 12356 | 0.020 |
Why?
|
| Toll-Like Receptors | 1 | 2008 | 593 | 0.020 |
Why?
|
| Senna Extract | 1 | 2004 | 3 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2014 | 5077 | 0.020 |
Why?
|
| Thioguanine | 1 | 2003 | 46 | 0.010 |
Why?
|
| Siblings | 1 | 2008 | 854 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 2009 | 13814 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2020 | 19233 | 0.010 |
Why?
|
| Telemedicine | 1 | 2021 | 2872 | 0.010 |
Why?
|
| Leukemic Infiltration | 1 | 2003 | 48 | 0.010 |
Why?
|
| Daunorubicin | 1 | 2003 | 158 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2016 | 9735 | 0.010 |
Why?
|
| Ammonia | 1 | 2004 | 239 | 0.010 |
Why?
|
| Sigmoidoscopy | 1 | 2003 | 156 | 0.010 |
Why?
|
| Internet | 1 | 2015 | 3056 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 2009 | 18111 | 0.010 |
Why?
|
| Carnitine | 1 | 2004 | 246 | 0.010 |
Why?
|
| Critical Care | 1 | 2015 | 2647 | 0.010 |
Why?
|
| Mutation | 2 | 2009 | 29786 | 0.010 |
Why?
|
| Respiration | 1 | 2009 | 1653 | 0.010 |
Why?
|
| Surgical Stapling | 1 | 2003 | 97 | 0.010 |
Why?
|
| Mesentery | 1 | 2003 | 205 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2017 | 14561 | 0.010 |
Why?
|
| Patient Discharge | 1 | 2015 | 3318 | 0.010 |
Why?
|
| Etoposide | 1 | 2003 | 641 | 0.010 |
Why?
|
| Registries | 1 | 2017 | 8091 | 0.010 |
Why?
|
| Cytarabine | 1 | 2003 | 692 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2011 | 6621 | 0.010 |
Why?
|
| Dilatation, Pathologic | 1 | 2003 | 520 | 0.010 |
Why?
|
| Pandemics | 1 | 2021 | 8385 | 0.010 |
Why?
|
| Pedigree | 1 | 2009 | 4642 | 0.010 |
Why?
|
| Hypnotics and Sedatives | 1 | 2009 | 1162 | 0.010 |
Why?
|
| Health Status | 1 | 2014 | 4034 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2015 | 6254 | 0.010 |
Why?
|
| Ubiquinone | 1 | 2002 | 188 | 0.010 |
Why?
|
| Middle Aged | 2 | 2015 | 213390 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 21833 | 0.010 |
Why?
|
| Monocytes | 1 | 2010 | 2596 | 0.010 |
Why?
|
| Calorimetry, Indirect | 1 | 2001 | 183 | 0.010 |
Why?
|
| Funnel Chest | 1 | 1981 | 71 | 0.010 |
Why?
|
| Peroxidase | 1 | 2003 | 611 | 0.010 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2001 | 361 | 0.010 |
Why?
|
| Sternum | 1 | 1981 | 177 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2008 | 4777 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2002 | 20130 | 0.010 |
Why?
|
| Antigens, CD1 | 1 | 2002 | 437 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2003 | 987 | 0.010 |
Why?
|
| Urinary Diversion | 1 | 1979 | 138 | 0.010 |
Why?
|
| Stress, Psychological | 1 | 2014 | 4245 | 0.010 |
Why?
|
| Protein Binding | 1 | 2011 | 9384 | 0.010 |
Why?
|
| Urinary Catheterization | 1 | 1979 | 202 | 0.010 |
Why?
|
| Spain | 1 | 1979 | 465 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 13991 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 2005 | 1547 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 2002 | 1880 | 0.010 |
Why?
|
| Medicare | 1 | 2015 | 6566 | 0.010 |
Why?
|
| Dexamethasone | 1 | 2003 | 1951 | 0.010 |
Why?
|
| Models, Animal | 1 | 2003 | 2173 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2008 | 4666 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 2002 | 1904 | 0.010 |
Why?
|
| Vitamins | 1 | 2002 | 1623 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2002 | 2499 | 0.010 |
Why?
|
| Killer Cells, Natural | 1 | 2002 | 2133 | 0.010 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 1994 | 224 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2002 | 3493 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2002 | 8436 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 57776 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2002 | 10183 | 0.000 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2003 | 11525 | 0.000 |
Why?
|
| Aged | 1 | 2015 | 163288 | 0.000 |
Why?
|
| Osteotomy | 1 | 1981 | 822 | 0.000 |
Why?
|